GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Cash Flow from Others

Respiratorius AB (XSAT:RESP) Cash Flow from Others : kr1.05 Mil (TTM As of Jun. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Respiratorius AB Cash Flow from Others?

Respiratorius AB's cash flow from others for the three months ended in Jun. 2024 was kr-0.05 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Jun. 2024 was kr1.05 Mil.


Respiratorius AB Cash Flow from Others Historical Data

The historical data trend for Respiratorius AB's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Respiratorius AB Cash Flow from Others Chart

Respiratorius AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Others
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Respiratorius AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Apr22 Sep22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 -0.64 1.93 -0.19 -0.05

Respiratorius AB Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.05 Mil.

Respiratorius AB Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Respiratorius AB's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Respiratorius AB Business Description

Traded in Other Exchanges
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.

Respiratorius AB Headlines

No Headlines